These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MicroRNAs in the regulation of immune cell functions--implications for atherosclerotic vascular disease. Zernecke A Thromb Haemost; 2012 Apr; 107(4):626-33. PubMed ID: 22318366 [TBL] [Abstract][Full Text] [Related]
4. Inflammation and immune system contribution to the etiology of atherosclerosis: mechanisms and methods of assessment. Salisbury D; Bronas U Nurs Res; 2014; 63(5):375-85. PubMed ID: 25171563 [TBL] [Abstract][Full Text] [Related]
5. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691 [TBL] [Abstract][Full Text] [Related]
6. miRNAs in atherosclerotic plaque initiation, progression, and rupture. Andreou I; Sun X; Stone PH; Edelman ER; Feinberg MW Trends Mol Med; 2015 May; 21(5):307-18. PubMed ID: 25771097 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role? Ma X; Ma C; Zheng X Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as Potential Biomarkers in Atherosclerosis. Churov A; Summerhill V; Grechko A; Orekhova V; Orekhov A Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703274 [TBL] [Abstract][Full Text] [Related]
9. Rupture of vulnerable atherosclerotic plaques: microRNAs conducting the orchestra? Haver VG; Slart RH; Zeebregts CJ; Peppelenbosch MP; Tio RA Trends Cardiovasc Med; 2010 Feb; 20(2):65-71. PubMed ID: 20656218 [TBL] [Abstract][Full Text] [Related]
10. Thrombosis formation on atherosclerotic lesions and plaque rupture. Badimon L; Vilahur G J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650 [TBL] [Abstract][Full Text] [Related]
11. Regulation of atherosclerotic plaque inflammation. Bäck M; Weber C; Lutgens E J Intern Med; 2015 Nov; 278(5):462-82. PubMed ID: 25823439 [TBL] [Abstract][Full Text] [Related]
12. Noncoding RNAs in vascular inflammation and atherosclerosis: recent advances toward therapeutic applications. Cochain C; Zernecke A Curr Opin Lipidol; 2014 Oct; 25(5):380-6. PubMed ID: 25051497 [TBL] [Abstract][Full Text] [Related]
13. Interferons as Essential Modulators of Atherosclerosis. Boshuizen MC; de Winther MP Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1579-88. PubMed ID: 25953648 [TBL] [Abstract][Full Text] [Related]
14. Toll like receptor 4 in atherosclerosis and plaque destabilization. den Dekker WK; Cheng C; Pasterkamp G; Duckers HJ Atherosclerosis; 2010 Apr; 209(2):314-20. PubMed ID: 19900676 [TBL] [Abstract][Full Text] [Related]
15. The co-inertia approach in identification of specific microRNA in early and advanced atherosclerosis plaque. Jovanović I; Zivković M; Jovanović J; Djurić T; Stanković A Med Hypotheses; 2014 Jul; 83(1):11-5. PubMed ID: 24815336 [TBL] [Abstract][Full Text] [Related]
16. The Role of Vascular Aging in Atherosclerotic Plaque Development and Vulnerability. Liberale L; Camici GG Curr Pharm Des; 2019; 25(29):3098-3111. PubMed ID: 31470777 [TBL] [Abstract][Full Text] [Related]